Brian S. Kim, MD, MTR

Vice President & Chief Biotechnology Officer
Northwell

Head of Intellectual Asset Management
Feinstein Institutes for Medical Research

Robin and Jack Ross Chair in Bioelectronic Medicine and Neuroimmunology and Professor
Institute of Bioelectronic Medicine

Biography

A leading dermatologist and physician-scientist, Dr. Kim was previously the Sol and Clara Kest Professor of Dermatology, Vice Chair of Research, Director of the Mark Lebwohl Center for Neuroinflammation at Icahn School of Medicine at Mount Sinai. He has >190 peer-reviewed publications, multiple NIH grants, designed pivotal clinical trials that led to novel FDA-approved treatments, and is an inventor of itch-centered technologies. He has been awarded the American Dermatological Association Young Leadership Award, International League of Dermatological Societies Young Dermatologist Achievement Award, American Skin Association Research Achievement Award in Discovery, Otto Braun-Falco Memorial Lecture Award, Stephen I Katz, MD, PhD International Lectureship Award from the Society for Investigative Dermatology, Donald Y. M. Leung, MD, PhD-JACI Editors Lectureship and Faculty Development Award from the American Academy of Asthma, Allergy & Immunology, and Marion B. Sulzberger, MD Research Award and Lectureship from the American Academy of Dermatology. He is co-founder of Alys Pharmaceuticals, an immuno-dermatology biotech company and Neurommune Therapeutics, a neuroinflammation-focused biotech company. Dr. Kim was awarded the role as the Lead of the Allen Discovery Center for Neuroimmune Interactions which is a $10 million multi-institutional center funded by the Paul G. Allen Frontiers Group and the Paul G. Allen Family Foundation.